Lyka Labs Share Price

107.610.27 (0.26%)
Volume: 35,459

Closed
Last Updated On: 28 Jun, 2024, 03:45 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Lyka Labs Share Price

107.610.27 (0.26%)
Volume: 35,459

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు

Lyka Labs share price insights

View All

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 16.77% outperformed its 3 year CAGR of 8.57%. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 81.31% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Employee & Interest Expense
Company has spent 4.4% of its operating revenues towards interest expenses and 24.07% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Pharma
Stock generated 81.31% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Lyka Labs Share Price Update
Lyka Labs Ltd. share price moved up by 0.26% from its previous close of Rs 107.34. Lyka Labs Ltd. stock last traded price is 107.61
Share Price Value
Today/Current/Last 107.61107.35
Previous Day 107.34107.30

Share Price	Value
Today/Current/Last	107.61107.35
Previous Day	107.34107.30

InsightsLyka Labs

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

-160.01

EPS - TTM

(₹)

-0.67

MCap

(₹ Cr.)

385.10

Sectoral MCap Rank

PB Ratio

(x)

5.61

Div Yield

(%)

0.00

Face Value

(₹)

10.00

Beta

1.16

VWAP

(₹)

107.24

52W H/L

(₹)

144.30 / 97.90

Lyka Labs Share Price Returns

1 Day	0.26%
1 Week	-0.23%
1 Month	1.18%
3 Months	1.42%
1 Year	-5.52%
3 Years	83.17%
5 Years	349.31%

ET Stock ScreenersTop Score Companies

Check whether Lyka Labs belongs to analysts' top-rated companies list?

View Stock Screeners

Lyka Labs News & Analysis

View all Lyka Labs Share News & Announcements

Lyka Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Lyka Labs Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Lyka Labs Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 16.77% outperformed its 3 year CAGR of 8.57%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 4.4% of its operating revenues towards interest expenses and 24.07% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	28.06	33.11	28.23	23.25	22.67
Total Income Growth (%)	-15.25	17.26	21.42	2.58	20.06
Total Expenses	28.61	28.54	27.84	23.70	22.82
Total Expenses Growth (%)	0.25	2.53	17.46	3.85	-12.52
EBIT	-0.56	4.56	0.39	-0.45	-0.15
EBIT Growth (%)	-112.17	1,055.94	-	-	-
Profit after Tax (PAT)	-2.09	2.01	-0.49	-1.85	-3.00
PAT Growth (%)	-203.65	-	-	-	-
EBIT Margin (%)	-1.98	13.79	1.40	-1.92	-0.67
Net Profit Margin (%)	-7.44	6.08	-1.72	-7.94	-13.22
Basic EPS (₹)	-3.83	0.53	-0.16	-0.57	-1.05

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	27.37	31.94	27.06	21.67	20.07
Total Income Growth (%)	-14.30	18.01	24.92	7.95	10.00
Total Expenses	27.55	28.28	26.33	22.01	20.19
Total Expenses Growth (%)	-2.58	7.39	19.62	9.06	-19.69
EBIT	-0.18	3.66	0.73	-0.35	-0.12
EBIT Growth (%)	-104.82	400.62	-	-	-
Profit after Tax (PAT)	-1.62	1.36	-0.29	-1.72	-3.01
PAT Growth (%)	-218.80	-	-	-	-
EBIT Margin (%)	-0.65	11.46	2.70	-1.61	-0.58
Net Profit Margin (%)	-5.92	4.27	-1.08	-7.94	-14.97
Basic EPS (₹)	-0.50	0.40	-0.10	-0.54	-1.05

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	112.65	96.47	196.18	87.81	64.58
Total Revenue Growth (%)	16.77	-50.82	123.41	35.98	-11.38
Total Expenses	113.17	102.25	130.41	100.83	93.23
Total Expenses Growth (%)	10.68	-21.60	29.34	8.15	6.97
Profit after Tax (PAT)	-2.49	-13.21	39.00	-11.55	-60.54
PAT Growth (%)	-	-133.88	-	-	-
Operating Profit Margin (%)	3.92	6.54	44.25	14.98	-13.96
Net Profit Margin (%)	-2.23	-14.19	20.09	-13.39	-98.45
Basic EPS (₹)	-0.79	-4.63	13.57	-4.07	-21.29

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	108.04	84.04	167.07	64.47	43.34
Total Revenue Growth (%)	28.56	-49.69	159.13	48.76	-0.96
Total Expenses	108.92	90.08	102.16	81.44	70.74
Total Expenses Growth (%)	20.92	-11.83	25.44	15.13	40.53
Profit after Tax (PAT)	-2.27	-13.29	39.90	-14.46	-55.39
PAT Growth (%)	-	-133.30	-	-	-3,295.99
Operating Profit Margin (%)	3.68	6.86	51.61	13.79	-20.58
Net Profit Margin (%)	-2.13	-16.48	24.27	-23.22	-135.93
Basic EPS (₹)	-0.72	-4.65	13.87	-5.08	-19.48

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	156.72	151.52	185.61	190.01	200.17
Total Assets Growth (%)	3.43	-18.37	-2.31	-5.07	-7.91
Total Liabilities	88.46	104.77	171.35	214.40	214.64
Total Liabilities Growth (%)	-15.57	-38.85	-20.08	-0.11	25.07
Total Equity	68.27	45.67	13.49	-25.09	-15.11
Total Equity Growth (%)	49.47	238.53	-	-	-133.02
Current Ratio (x)	1.35	1.36	0.53	0.59	0.54
Total Debt to Equity (x)	0.84	1.55	9.66	-6.24	-9.75
Contingent Liabilities	0.00	36.81	46.56	31.82	47.74

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	185.88	178.86	208.51	213.37	221.27
Total Assets Growth (%)	3.92	-14.22	-2.28	-3.57	-11.03
Total Liabilities	86.55	101.35	163.30	208.25	201.85
Total Liabilities Growth (%)	-14.60	-37.94	-21.58	3.17	35.29
Total Equity	99.33	76.43	44.44	4.41	18.78
Total Equity Growth (%)	29.96	71.98	907.71	-76.52	-80.95
Current Ratio (x)	1.39	1.41	0.51	0.58	0.55
Total Debt to Equity (x)	0.57	0.92	2.87	36.39	7.22
Contingent Liabilities	0.00	24.58	35.34	22.78	51.81

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	1.77	8.95	79.25	8.81	5.32
Net Cash used in Investing Activities	-9.49	7.35	-6.17	-0.16	-0.11
Net Cash flow from Financing Activities	1.95	-21.64	-63.18	-11.80	3.38
Net Cash Flow	-11.71	-5.34	9.90	-3.15	8.60
Closing Cash & Cash Equivalent	5.95	11.71	17.05	7.15	10.30
Closing Cash & Cash Equivalent Growth (%)	-49.20	-31.32	138.35	-30.56	555.44
Total Debt/ CFO (x)	32.36	7.89	1.63	18.27	26.27

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	3.09	6.87	76.53	5.75	-11.45
Net Cash used in Investing Activities	-8.61	6.77	-4.33	0.13	0.13
Net Cash flow from Financing Activities	2.71	-20.33	-63.35	-7.75	19.61
Net Cash Flow	-8.70	-6.69	8.85	-1.88	8.28
Closing Cash & Cash Equivalent	5.89	8.70	15.38	6.53	8.40
Closing Cash & Cash Equivalent Growth (%)	-32.31	-43.47	135.63	-22.32	9,227.75
Total Debt/ CFO (x)	18.31	10.18	1.67	27.90	-11.85

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	-3.65	-29.07	292.38	0.00	0.00
Return on Capital Employed (%)	3.66	5.12	99.57	9.17	-6.41
Return on Assets (%)	-1.58	-8.71	21.01	-6.08	-30.24
Interest Coverage Ratio (x)	3.51	1.71	5.13	0.50	-0.43
Asset Turnover Ratio (x)	0.72	0.44	0.82	45.39	30.71
Price to Earnings (x)	-142.86	-24.33	9.98	-6.46	-0.60
Price to Book (x)	5.14	7.07	29.17	-2.89	-2.55
EV/EBITDA (x)	23.42	18.85	4.86	10.82	-286.39
EBITDA Margin (%)	15.44	21.74	53.19	24.63	-0.94

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	-2.28	-17.38	89.79	-327.92	-294.93
Return on Capital Employed (%)	2.61	3.71	73.87	5.09	-5.05
Return on Assets (%)	-1.22	-7.42	19.13	-6.77	-25.03
Interest Coverage Ratio (x)	3.38	1.65	5.03	0.65	-0.44
Asset Turnover Ratio (x)	0.58	0.42	0.78	0.29	18.41
Price to Earnings (x)	-156.25	-24.21	9.76	-5.16	-0.66
Price to Book (x)	3.53	4.20	8.75	16.93	1.95
EV/EBITDA (x)	24.76	20.14	5.01	13.78	-265.51
EBITDA Margin (%)	15.23	23.64	60.97	26.71	-1.52

Financial InsightsLyka Labs

Income (P&L)

- Beating 3 Yr Revenue CAGR
  Company's annual revenue growth of 16.77% outperformed its 3 year CAGR of 8.57%. (Source: Consolidated Financials)
- Employee & Interest Expense
  Company has spent 4.4% of its operating revenues towards interest expenses and 24.07% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Lyka Labs Peer Comparison

Lyka Labs Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 81.31% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 81.31% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Lyka Labs Stock Performance	0.26	-0.59	-6.02	-9.91	1.76	81.31	334.79
Zim Laboratories Stock Performance	0.41	8.89	-0.94	8.20	-1.25	0.00	0.00
Wanbury Ltd Stock Performance	-0.70	3.97	13.88	1.02	172.08	52.78	757.57
Venus Remedies Stock Performance	2.62	11.04	19.84	7.29	58.02	13.34	1147.13
Medico Remedies Stock Performance	-3.05	10.22	-1.85	-51.94	-50.84	0.00	0.00
Add More

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 81.31% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 81.31% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Lyka Labs	-160.01	5.64	-3.65	3.66	-1.58	8.57	3.92	-2.35	-0.79	1.35	0.84	32.36
Zim Laboratories	30.87	2.23	7.22	10.63	3.85	6.30	8.31	4.69	3.54	1.43	0.45	6.53
Wanbury Ltd	9.27	18.57	200.26	46.34	16.29	13.43	10.41	9.72	17.10	0.74	3.94	27.64
Venus Remedies	16.91	0.99	5.84	8.17	4.54	2.56	7.43	4.73	21.31	4.53	0.08	1.11
Medico Remedies	42.24	6.69	15.83	22.77	8.61	5.95	8.38	5.72	1.00	1.72	0.15	3.30
Add More

Annual Ratios (%)

Choose from Peers

Par Drugs & Chemical
SMS Lifesciences Ind
Brooks Labs
Vaishali Pharma
Bal Pharma

Choose from Stocks

See All Parameters

Peers InsightsLyka Labs

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 81.31% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 81.31% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Lyka Labs Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Lyka Labs Shareholding as on 31 Mar 2024
Category 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Promoters 54.81 54.81 54.81 54.58
Pledge 0.00 0.00 0.00 0.00
FII 0.17 0.17 0.18 0.17
DII 0.81 0.62 0.41 0.41
Mutual Funds 0.01 0.01 0.01 0.01
Others 44.20 44.40 44.60 44.84
Showing Shareholding as on 31 Mar 2024
Category No. of Shares Percentage % Change QoQ
Promoters 1,81,37,509 54.81 % 0.00
Pledge 0 0.00 % 0.00
FII 55,934 0.17 % 0.00
DII 2,67,051 0.81 % 0.19
MF 3,400 0.01 % 0.00
Others 1,46,29,506 44.20 % -0.19

Category	31 Mar 2024	31 Dec 2023	30 Sep 2023	30 Jun 2023
Promoters	54.81	54.81	54.81	54.58
Pledge	0.00	0.00	0.00	0.00
FII	0.17	0.17	0.18	0.17
DII	0.81	0.62	0.41	0.41
Mutual Funds	0.01	0.01	0.01	0.01
Others	44.20	44.40	44.60	44.84

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,81,37,509	54.81 %	0.00
Pledge	0	0.00 %	0.00
FII	55,934	0.17 %	0.00
DII	2,67,051	0.81 %	0.19
MF	3,400	0.01 %	0.00
Others	1,46,29,506	44.20 %	-0.19

MF Ownership

MF Ownership details are not available.

Corporate Actions

Lyka Labs Board Meeting/AGM
Lyka Labs Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 21, 2024	May 10, 2024	Board Meeting	Audited Results & Others
Apr 16, 2024	Apr 08, 2024	Board Meeting	Others
Feb 24, 2024	Jan 23, 2024	POM	-
Feb 20, 2024	Jan 19, 2024	COM	-
Feb 08, 2024	Jan 31, 2024	Board Meeting	Quarterly Results

Dividend announcements are not available.
All Types Ex-Date Record Date Announced on Details
Rights Oct 22, 1993 Nov 17, 1993 Sep 30, 1993 Rights ratio: 1 share for every 2 held at a price of Rs 30.0

All Types	Ex-Date	Record Date	Announced on	Details
Rights	Oct 22, 1993	Nov 17, 1993	Sep 30, 1993	Rights ratio: 1 share for every 2 held at a price of Rs 30.0

About Lyka Labs

Lyka Labs Ltd., incorporated in the year 1976, is a Small Cap company (having a market cap of Rs 384.06 Crore) operating in Pharmaceuticals sector. Lyka Labs Ltd. key Products/Revenue Segments include Formulations, Bulk Drugs, Processing Charges, Other Operating Revenue, Royalty Income, Export Incentives for the year ending 31-Mar-2023. Show More

Executives
Auditors

BJ
Babulal Jain
Chairman
KG
Kunal Gandhi
Managing Director & CEO
YB
Yogesh B Shah
Executive Director & CFO
PG
Prashant Godha
Non Executive Director
SM
Shashil Mendosa
Non Executive Director
DP
Dhara P Shah
Independent Director
SP
Sandeep P Parikh
Independent Director
KP
Kishore P Shah
Co. Secretary & Compl. Officer
Show More
D Kothary & Co.

Industry

Pharma - Indian

Key Indices Listed on

Address

4801/B & 4802/A,G.I.D.C. Industrial Estate,Ankleshwar, Gujarat - 393002

Contact

[email protected].

http://www.lykalabs.com

More Details

FAQs about Lyka Labs share

1. What's the Lyka Labs share price today?
Lyka Labs share price was Rs 107.61 as on 28 Jun, 2024, 03:45 PM IST. Lyka Labs share price was up by 0.26% based on previous share price of Rs 107.25. Lyka Labs share price trend:
- Last 1 Month: Lyka Labs share price moved up by 1.18%
- Last 3 Months: Lyka Labs share price moved up by 1.42%
- Last 12 Months: Lyka Labs share price moved down 5.52%
- Last 3 Years: Lyka Labs Share price moved up by 83.17%
2. Who are the key owners of Lyka Labs stock?
3. What are the Lyka Labs quarterly results?
On Consoldiated basis, Lyka Labs reported a total income and loss of Rs 28.06 Cr and Rs -2.09 respectively for quarter ending 2024-03-31. Total Income and loss for the year ending 2024-03-31 was Rs 112.65 Cr and Rs -2.49 Cr.
4. What is the CAGR of Lyka Labs?
The CAGR of Lyka Labs is 6.56.
5. What are the returns for Lyka Labs share?
Return Performance of Lyka Labs Shares:
- 1 Week: Lyka Labs share price moved down by 0.23%
- 1 Month: Lyka Labs share price moved up by 1.18%
- 3 Month: Lyka Labs share price moved up by 1.42%
- 6 Month: Lyka Labs share price moved down by 11.61%
6. Who is the CEO of Lyka Labs?
Kunal Gandhi is the Managing Director & CEO of Lyka Labs
7. What is Lyka Labs's 52 week high / low?
Lyka Labs share price saw a 52 week high of Rs 144.30 and 52 week low of Rs 97.90.
8. Which are the key peers to Lyka Labs?
Top 10 Peers for Lyka Labs are Medico Remedies Ltd., Par Drugs & Chemicals Ltd., SMS Lifesciences India Ltd., Brooks Laboratories Ltd., Venus Remedies Ltd., Zim Laboratories Ltd., Wanbury Ltd., Vaishali Pharma Ltd., Bal Pharma Ltd. and Alpa Laboratories Ltd.
9. What is the PE & PB ratio of Lyka Labs?
The PE ratio of Lyka Labs stands at -159.18, while the PB ratio is 5.2.
10. What is the market cap of Lyka Labs?
Within the Pharmaceuticals sector, Lyka Labs stock has a market cap rank of 83. Lyka Labs has a market cap of Rs 385.10 Cr.
11. Who's the chairman of Lyka Labs?
Babulal Jain is the Chairman of Lyka Labs
12. What are the key metrics to analyse Lyka Labs Share Price?
Lyka Labs share can be quickly analyzed on following metrics:
- Stock's PE is -160.01
- Price to Book Ratio of 5.61

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	0.04%
1 Week	-0.42%
1 Month	0.94%
3 Months	1.32%
1 Year	-4.73%
3 Years	79.52%
5 Years	361.72%

Lyka Labs Share Price

Lyka Labs Share Price

Lyka Labs share price insights

InsightsLyka Labs

Key Metrics

Key Metrics

Lyka Labs Share Price Returns

ET Stock ScreenersTop Score Companies

Lyka Labs News & Analysis

Lyka Labs Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Lyka Labs Share Recommendations

Lyka Labs Financials

Income (P&L)

Balance Sheet

Cash Flow

Ratios

Insights

Financial InsightsLyka Labs

Lyka Labs Peer Comparison

Lyka Labs Stock Performance

Ratio Performance

Insights

Insights

Ratio Performance

Peers InsightsLyka Labs

Lyka Labs Shareholding Pattern

QOQ Change

Total Shareholdings

MF Ownership

Top Searches:

Corporate Actions

Lyka Labs Board Meeting/AGM

Lyka Labs Dividends

About Lyka Labs

Executives

Auditors

More Details

FAQs about Lyka Labs share

Trending in Markets

Lyka Labs Quick Links

Equity Quick Links

More from Markets